Work

PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin

Year: 2024

Type: article

Source: Journal of Pediatric Surgery

DOI: 10.1016/j.jpedsurg.2024.03.014

Authors: Janet R. Julson, Colin H. Quinn, Nazia Nazam, Laura V. Bownes, Jerry E. Stewart, Elizabeth A. Beierle

Institutions: University of Alabama at Birmingham, UAB Medicine

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Rally Foundation, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Hyundai Hope On Wheels

Awards: Medical Scientist Training Program, Rheumatic Diseases Core Centers (P30), Surgical Oncology Research Training Program, Comprehensive Cancer Center Support Grant

OpenAlex ID: W4392869224

FWCI: 0.803

Cites: 38

Cited by: 3

Related to: 10